Direkt zum Inhalt
Merck

1222818

USP

Dissolution Performance Verification Standard - Prednisone (30 tablets)

United States Pharmacopeia (USP) Reference Standard

Synonym(e):

DPVS-Prednisone

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise


About This Item

UNSPSC-Code:
41116107
NACRES:
NA.24

Qualität

pharmaceutical primary standard

Agentur

certified by the USP

API-Familie

prednisone

Form

tablet

Hersteller/Markenname

USP

Konzentration

10 mg/tablet (nominal prednisone content per tablet)

Anwendung(en)

pharmaceutical

Format

mixture

Lagertemp.

room temp

Allgemeine Beschreibung

The USP Performance Verification Test (PVT) is an essential aspect of the General Chapter <711> Dissolution that assesses the comprehensive performance of Dissolution Apparatus 1 (basket) and Dissolution Apparatus 2 (paddle). DPVS - Prednisone Tablets is specially engineered by USP to use as a reference standard for PVT of apparatus used in dissolution testing for the following reasons:

  • High stability and ease of use
  • High sensitivity to operational and mechanical variables of instrument setup
  • Low sensitivity to media degassing
  • Low tablet-to-tablet variability
These features help enable you to identify any differences from the ideal dissolution instrument setup so you can have confidence in your dissolution testing results.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets, has been developed and issued under the authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Anwendung

Dissolution Performance Verification Standard (DPVS) – Prednisone tablets USP reference standard is used for the comprehensive qualification of dissolution instruments using performance verification testing (PVT) to achieve reliable results that reflect the quality of the drug product.

Komponenten

Each tablet contains: Dicalcium Phosphate Anhydrous (7757-93-9), Microcrystalline Cellulose (9004-34-6), Colloidal silicone dioxide (112945-52-5), Magnesium Stearate (557-04-0), Prednisone (53-03-2), Sodium Dodecyl Sulfate Fine (151-21-3), Sodium Starch Glycolate Type A (9063-38-1)

Hinweis zur Analyse

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.

Sonstige Hinweise

Sales restrictions may apply.

Piktogramme

Health hazard

Signalwort

Warning

H-Sätze

Gefahreneinstufungen

STOT RE 2 Inhalation

Lagerklassenschlüssel

11 - Combustible Solids

WGK

WGK 3


Analysenzertifikate (COA)

Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.